Literature DB >> 21671442

Why do covariates defined by International Classification of Diseases codes fail to remove confounding in pharmacoepidemiologic studies among seniors?

Michael L Jackson1, Jennifer C Nelson, Lisa A Jackson.   

Abstract

PURPOSE: The common practice of using administrative diagnosis codes as the sole source of data on potential confounders in pharmacoepidemiologic studies has been shown to leave substantial residual confounding. We explored reasons why adjustment for comorbid illness defined from International Classification of Diseases (ICD) codes fails to remove confounding.
METHODS: We used data from a case-control study among immunocompetent seniors enrolled in Group Health to estimate bias in the estimated association between receipt of influenza vaccine and the risk of community-acquired pneumonia during non-influenza control periods and to estimate the effects of adjusting for comorbid illnesses defined from either ICD codes or the medical record. We also estimated the accuracy of ICD codes for identifying comorbid illnesses compared with the gold standard of medical record review.
RESULTS: Sensitivity of ICD codes for illnesses recorded in the medical record ranged from 59 to 97% (median, 76%). Strong confounding was present in the vaccine/pneumonia association, as evidenced by the non-null odds ratio of 0.60 (95% confidence interval, 0.38-0.95) during this control period. Adjusting for the presence/absence of comorbid illnesses defined from either medical record review (odds ratio, 0.73) or from ICD codes (odds ratio, 0.68) left considerable residual confounding.
CONCLUSIONS: ICD codes may fail to control for confounding because they often lack sensitivity for detecting comorbid illnesses and because measures of the presence/absence of comorbid illnesses may be insufficient to remove confounding. These findings call for caution in the use of ICD codes to control for confounding.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671442     DOI: 10.1002/pds.2160

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  6 in total

1.  Controlling Time-Dependent Confounding by Health Status and Frailty: Restriction Versus Statistical Adjustment.

Authors:  Leah J McGrath; Alan R Ellis; M Alan Brookhart
Journal:  Am J Epidemiol       Date:  2015-04-12       Impact factor: 4.897

2.  Do claims-based comorbidities adequately capture case mix for surgical site infections?

Authors:  Hilal Maradit Kremers; Laura W Lewallen; Brian D Lahr; Tad M Mabry; James M Steckelberg; Daniel J Berry; Arlen D Hanssen; Elie F Berbari; Douglas R Osmon
Journal:  Clin Orthop Relat Res       Date:  2014-12-06       Impact factor: 4.176

3.  Hospitalization and skilled nursing care are predictors of influenza vaccination among patients on hemodialysis: evidence of confounding by frailty.

Authors:  Leah J McGrath; Stephen R Cole; Abhijit V Kshirsagar; David J Weber; Til Stürmer; M Alan Brookhart
Journal:  Med Care       Date:  2013-12       Impact factor: 2.983

4.  Validation sampling can reduce bias in health care database studies: an illustration using influenza vaccination effectiveness.

Authors:  Jennifer Clark Nelson; Tracey Marsh; Thomas Lumley; Eric B Larson; Lisa A Jackson; Michael L Jackson
Journal:  J Clin Epidemiol       Date:  2013-08       Impact factor: 6.437

Review 5.  Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review.

Authors:  Cornelius Remschmidt; Ole Wichmann; Thomas Harder
Journal:  BMC Infect Dis       Date:  2015-10-17       Impact factor: 3.090

6.  Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic.

Authors:  Michael L Jackson; Onchee Yu; Jennifer C Nelson; Allison Naleway; Edward A Belongia; Roger Baxter; Komal Narwaney; Steven J Jacobsen; David K Shay; Lisa A Jackson
Journal:  Am J Epidemiol       Date:  2013-08-26       Impact factor: 4.897

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.